CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
Taking everything into account, CLARI scores 2 out of 10 in our fundamental rating. CLARI was compared to 24 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
In the past year CLARI had a positive cash flow from operations.
In multiple years CLARI reported negative net income over the last 5 years.
CLARI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -0.39%, CLARI is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CLARI has a worse Return On Equity (-1.49%) than 79.17% of its industry peers.
The Return On Invested Capital of CLARI (1.86%) is worse than 79.17% of its industry peers.
CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 6.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
Looking at the Operating Margin, with a value of 5.44%, CLARI is in line with its industry, outperforming 45.83% of the companies in the same industry.
In the last couple of years the Operating Margin of CLARI has declined.
CLARI has a better Gross Margin (91.68%) than 95.83% of its industry peers.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
CLARI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLARI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.65, we must say that CLARI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.65, CLARI is doing worse than 75.00% of the companies in the same industry.
CLARI has a debt to FCF ratio of 13.44. This is a negative value and a sign of low solvency as CLARI would need 13.44 years to pay back of all of its debts.
CLARI has a Debt to FCF ratio of 13.44. This is in the lower half of the industry: CLARI underperforms 75.00% of its industry peers.
CLARI has a Debt/Equity ratio of 1.78. This is a high value indicating a heavy dependency on external financing.
CLARI's Debt to Equity ratio of 1.78 is on the low side compared to the rest of the industry. CLARI is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.65 |
ROIC/WACC0.46
WACC4.03%
2.3 Liquidity
A Current Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
CLARI's Current ratio of 0.56 is on the low side compared to the rest of the industry. CLARI is outperformed by 91.67% of its industry peers.
CLARI has a Quick Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.56, CLARI is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.18%, which is quite impressive.
CLARI shows a small growth in Revenue. In the last year, the Revenue has grown by 5.73%.
Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.62% yearly.
Based on estimates for the next years, CLARI will show a small growth in Revenue. The Revenue will grow by 4.63% on average per year.
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y4.33%
Revenue Next 3Y4.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLARI is valuated quite expensively with a Price/Forward Earnings ratio of 36.66.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLARI indicates a slightly more expensive valuation: CLARI is more expensive than 75.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CLARI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 36.66 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLARI is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLARI indicates a rather cheap valuation: CLARI is cheaper than 91.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.09 | ||
| EV/EBITDA | 9.42 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 64.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.37%
EPS Next 3Y64.62%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.77, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, CLARI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPA:CLARI (7/11/2025, 7:00:00 PM)
5.135
-0.21 (-3.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners42.42%
Inst Owner ChangeN/A
Ins Owners5.64%
Ins Owner ChangeN/A
Market Cap1.83B
Analysts75.38
Price Target3.35 (-34.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.71%
PT rev (3m)27.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 36.66 | ||
| P/S | 0.35 | ||
| P/FCF | 3.09 | ||
| P/OCF | 2.03 | ||
| P/B | 0.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.42 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.14
Fwd EY2.73%
FCF(TTM)1.66
FCFY32.38%
OCF(TTM)2.53
OCFY49.23%
SpS14.84
BVpS10.37
TBVpS-5.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.65 |
F-Score5
WACC4.03%
ROIC/WACC0.46
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year3.9%
Revenue Next 2Y4.33%
Revenue Next 3Y4.63%
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year308.46%
EBIT Next 3Y69.88%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%